BuemiM., VaccaroM., SturialeA.. Recombinant human erythropoietin influences revascularization and healing in a rat model of random ischaemic flaps.Acta Derm Venereol2002; 82(6): 411–7.
3.
HeeschenC., AcherA., LehmannR.. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization.Blood2003; 102: 1340–6.
4.
ParsaC.J., MatsumotoA., KimJ.. A novel protective effect of erythropoietin in the infarcted heart.J Clin Invest2003112: 999–1007.
5.
OrlicD., KajsturaJ., ChimentiS.. Mobilized bone marrow cells repair the infracted heart, improving function and survival.PNAS2001, 98(18): 10344–9.
6.
ImazuruT., MatsushitaS., HyodoK.. Erythropoietin enhances arterioles more significantly than it does capillaries in an infarcted rat heart model.Int Heart J2008; 50: 801–10.
7.
MoonC., KrawczykM., PaikD.. Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties.JPET2006; 316(3): 999–1005.
8.
FiordalisoF., ChimentiS., StaszewskyL.. A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury.PNAS2005; 102(6): 2046–51.
9.
BrinesM., PatelN.S.A., VillaP.. Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin.PNAS2008; 105(31): 10925–30.
10.
ErbayraktarS., GrassoG., SfacteriaA.. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo.PNAS2003; 100(11): 6741–6.
11.
KobayashiH., MinatoguchiS., YasudaS.. Post-infarct treatment with an erythropoietin-gelatin hydrogel drug delivery system for cardiac repair.Cardiovasc Res2008; 79: 611–20.
12.
CoplandI.B., JolicoeurE.M., GillisM.A.. Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties.Cardiovasc Res.
13.
RibattiD., MarzulloA., GentileA.. Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma.Histopathology2007; 50: 591–6.
14.
HardeeM.E., CaoY., FuP., JiangX., ZhaoY., RabbaniZ.N., VujaskovicZ., DewhirstM.W., ArcasoyM.O.Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.PLoS One2007; 2(6): e549.
